Welcome to Activiomics

Announcement 27th March 2012

Biomarker Specialist Activiomics appoints Dr Trevor Nicholls as Non-Executive Chairman

Activiomics Limited, the developer of innovative biomarker technologies, has announced the appointment of industry leader Dr Trevor Nicholls to its Board as Non-Executive Chairman.

Read the full announcement here..

About Activiomics

Activiomics has developed innovative technologies using mass spectrometry to interrogate and interpret the activity of cellular signalling pathways.

Activiomics partners with the pharmaceutical and biotechnology industry to generate high value information using its novel TIQUAS platform. This has significant advantages over existing phosphoproteomics techniques

Click here to find out more about our technology

New Vacancies

Significant commercial traction and venture capital investment with Activiomics is currently driving rapid expansion of our team. We're always looking for the best people to join us.

Click here to see our current vacancies page

Contact us for more information